Taken together, these clinical data suggest that SOCS1 expression is reduced at both the mRNA and protein levels in PCa tissues and that this reduction is closely associated with the upregulation of miR-30d expression. The gene discussed is SOCS1; the disease is posterior cortical atrophy.